Amgen’s Cancer Therapy Meets Key Goal in Phase 3 Gastric Cancer Study
Amgen announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6)…
Siemens Healthineers Announces Theranostics Research Collaboration With MGH
Siemens Healthineers Molecular Imaging has entered into a research collaboration with leading…
Unpacking Pediatric Stem Cell Transplants: Insights from Dr. Kevin McNerney at Lurie Children’s Hospital
Dr. McNerney shared fascinating insights into this life-saving treatment. He explained how…
Cleveland Clinic Abu Dhabi, M42, and Gunma University Collaborate to Advance Heavy Ion Cancer Therapy
: M42, a global health champion powered by AI and technology, and…
M42 and Yamagata University partner to advance heavy ion therapy research
Abu Dhabi, United Arab Emirates, 30 April 2025: M42, a global health…
Game-Changing Cancer Treatment: AbbVie and Umoja Biopharma Partner Up
North Chicago, USA- Pharmaceutical giant AbbVie and early clinical-stage biotech company Umoja…
